Answers are grounded in this paper and cite their sources.
• The manuscript explores the innovative use of brain-dead patients as a crucial pre-clinical model for transplantation studies, particularly in xenotransplantation. By utilizing brain-dead patients, researchers can assess surgical complications, immune responses, and organ function without the ethical concerns associated with living subjects. The review highlights the complexities of managing systemic physiological responses in brain-dead patients and emphasizes the need for sophisticated extracorporeal life support systems to maintain organ function during research. • Additionally, the manuscript addresses the ethical and legal considerations of using brain-dead patients, underscoring the importance of informed consent, family communication, and robust regulatory oversight. It underscores the potential of xenotransplantation to alleviate the global shortage of transplantable organs, marking a significant advancement in transplant medicine and offering hope for future therapeutics. This review explores the use of brain-dead organ recipients for transplantation studies, focusing on recent advancements and the scientific rationale behind this approach. Brain-dead patients serve as a crucial pre-clinical model to test the safety and feasibility of xenotransplantation, allowing researchers to assess surgical complications, immune responses, and organ function without the ethical concerns associated with living human subjects. Notable studies from the University of Alabama at Birmingham, the New York University, the University of Pennsylvania and the Air Force Medical University in Xi'an have demonstrated the potential of genetically modified pig organs, such as kidneys, hearts and livers, to reduce immune rejection and improve graft survival. These experiments highlight the complexities of managing systemic physiological responses and the need for sophisticated extracorporeal life support systems. Additionally, the ethical and legal implications of using brain-dead patients for such experimental procedures are considered, underscoring the importance of informed consent and regulatory oversight. This review underscores the promise of xenotransplantation in addressing organ shortages and advancing transplant medicine.
No takes yet. Share an insight, caveat, or question.
Ciarlini et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: